Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human
G Michel, C Pomares, B Ferrua, P Marty - Acta tropica, 2011 - Elsevier
Leishmaniasis due to Leishmania infantum (syn. L. chagasi) infection is a zoonotic disease
present mainly in Mediterranean basin, central Asia and Brazil. Besides a limited number of …
present mainly in Mediterranean basin, central Asia and Brazil. Besides a limited number of …
Diagnosis of visceral leishmaniasis: developments over the last decade
G Srividya, A Kulshrestha, R Singh, P Salotra - Parasitology research, 2012 - Springer
Diagnostic parameters for visceral leishmaniasis (VL), a potentially fatal parasitic disease
caused by Leishmania donovani, have been redefined in the last decade with the …
caused by Leishmania donovani, have been redefined in the last decade with the …
Evaluation of a novel chromatographic immunoassay based on Dual-Path Platform technology (DPP® CVL rapid test) for the serodiagnosis of canine visceral …
G Grimaldi Jr, A Teva, AL Ferreira… - Transactions of the …, 2012 - academic.oup.com
Canine visceral leishmaniasis (CVL) is the major source of human visceral leishmaniasis
(VL) and is transmitted from dogs to sand flies to humans. To control the spread of this …
(VL) and is transmitted from dogs to sand flies to humans. To control the spread of this …
Towards a More Precise Serological Diagnosis of Human Tegumentary Leishmaniasis Using Leishmania Recombinant Proteins
AP Souza, M Soto, JML Costa, VS Boaventura… - PLoS …, 2013 - journals.plos.org
Background Exposure to Leishmania induces a humoral immune response that can be used
as a marker of parasite exposure. Methodology/Principal Findings Herein, ELISA was used …
as a marker of parasite exposure. Methodology/Principal Findings Herein, ELISA was used …
Systematic review of biomarkers to monitor therapeutic response in leishmaniasis
AE Kip, M Balasegaram, JH Beijnen… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Recently, there has been a renewed interest in the development of new drugs for the
treatment of leishmaniasis. This has spurred the need for pharmacodynamic markers to …
treatment of leishmaniasis. This has spurred the need for pharmacodynamic markers to …
[HTML][HTML] Application of recombinant proteins for serodiagnosis of visceral leishmaniasis in humans and dogs
M Farahmand, H Nahrevanian - Iranian biomedical journal, 2016 - ncbi.nlm.nih.gov
Visceral leishmaniasis (VL) is a zoonotic disease caused by leishmania species. Dogs are
considered to be the main reservoir of VL. A number of methods and antigen-based assays …
considered to be the main reservoir of VL. A number of methods and antigen-based assays …
Leishmania and leishmaniasis
A Kumar - 2013 - Springer
This book provides substantial knowledge in sequence on the protozoan parasite
Leishmania and disease globally caused by this parasite known as Leishmaniasis. The life …
Leishmania and disease globally caused by this parasite known as Leishmaniasis. The life …
A urine-based polymerase chain reaction method for the diagnosis of visceral leishmaniasis in immunocompetent patients
M Motazedian, M Fakhar, MH Motazedian… - … and infectious disease, 2008 - Elsevier
In the Mediterranean basin and Middle East, including Iran, visceral leishmaniasis (VL), also
known as kala-azar, is caused by Leishmania donovani infantum. For the first time, the use …
known as kala-azar, is caused by Leishmania donovani infantum. For the first time, the use …
Immunoproteomic Identification and Characterization of Leishmania Membrane Proteins as Non-Invasive Diagnostic Candidates for Clinical Visceral Leishmaniasis
SA Ejazi, A Bhattacharyya, ST Choudhury, S Ghosh… - Scientific reports, 2018 - nature.com
Visceral leishmaniasis (VL), a potentially fatal disease is an outcome of infection caused by
the parasite Leishmania donovani. The clinical diagnostic tests for this disease are still …
the parasite Leishmania donovani. The clinical diagnostic tests for this disease are still …
Systematic review on antigens for serodiagnosis of visceral leishmaniasis, with a focus on East Africa
Background Accurate and accessible diagnosis is key for the control of visceral
leishmaniasis (VL). Yet, current diagnostic tests for VL have severe limitations: they are …
leishmaniasis (VL). Yet, current diagnostic tests for VL have severe limitations: they are …